Healthcare - Biotechnology - NASDAQ - US
$ 2.62
-8.07 %
$ 148 M
Market Cap
-2.15
P/E
INCOME STATEMENT
0
REVENUE
-86.5 M
OPERATING INCOME
-82.4 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Black Diamond Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 437 K |
| Gross Profit | -437 K |
| Operating Expenses | 86.5 M |
| Operating Income | -86.5 M |
| Other Expenses | -4.02 M |
| Net Income | -82.4 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 0.4 | 3.2 | 2.2 | 0.6 | 47 K | 44 K | 24 K |
| Gross Profit | (0.4) | (3.2) | (2.2) | (0.6) | 47 K | 44 K | 24 K |
| OPERATING INCOME | |||||||
| Operating Expenses | 86.5 | 92.8 | 126.9 | 69.6 | 29.3 | 8.9 | 4.1 |
| Selling, General and Administrative Expenses | 27.1 | 28.4 | 30.0 | 21.4 | 7.6 | 2.0 | 0.7 |
| Research and Development Expenses | 59.4 | 64.4 | 96.8 | 48.2 | 21.8 | 7.0 | 3.5 |
| Operating Income | (86.5) | (92.8) | (126.9) | (69.6) | (8.9) | (8.9) | (4.1) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 0 | (3.9) | 0 | 1 K | 0 | 0 | 65 K |
| Total Other Income | 4.0 | 1.7 | 1.3 | 2.3 | (5.9) | 27 K | (0.5) |
| Pre-Tax Income | (82.4) | (88.9) | (125.6) | (67.3) | (35.3) | (8.9) | (4.6) |
| NET INCOME | |||||||
| Tax Provision | 0 | (4.4) | (2.4) | (1.8) | 5.9 | 27 K | 59 K |
| Net Income | (82.4) | (84.5) | (123.2) | (65.5) | (41.1) | (8.9) | (4.6) |
| EPS | 1.88 | 2.33 | 3.4 | 1.99 | 1.15 | 0.64 | 0.64 |